Your browser doesn't support javascript.
loading
TP53 mutations are associated with primary endocrine resistance in luminal early breast cancer.
Grote, Isabel; Bartels, Stephan; Kandt, Leonie; Bollmann, Laura; Christgen, Henriette; Gronewold, Malte; Raap, Mieke; Lehmann, Ulrich; Gluz, Oleg; Nitz, Ulrike; Kuemmel, Sherko; Zu Eulenburg, Christine; Braun, Michael; Aktas, Bahriye; Grischke, Eva-Maria; Schumacher, Claudia; Luedtke-Heckenkamp, Kerstin; Kates, Ronald; Wuerstlein, Rachel; Graeser, Monika; Harbeck, Nadia; Christgen, Matthias; Kreipe, Hans.
Afiliación
  • Grote I; Hannover Medical School, Institute of Pathology, Hannover, Germany.
  • Bartels S; Hannover Medical School, Institute of Pathology, Hannover, Germany.
  • Kandt L; Hannover Medical School, Institute of Pathology, Hannover, Germany.
  • Bollmann L; Hannover Medical School, Institute of Pathology, Hannover, Germany.
  • Christgen H; Hannover Medical School, Institute of Pathology, Hannover, Germany.
  • Gronewold M; Hannover Medical School, Institute of Pathology, Hannover, Germany.
  • Raap M; Hannover Medical School, Institute of Pathology, Hannover, Germany.
  • Lehmann U; Hannover Medical School, Institute of Pathology, Hannover, Germany.
  • Gluz O; West German Study Group, Moenchengladbach, Germany.
  • Nitz U; Ev. Bethesda Hospital, Moenchengladbach, Germany.
  • Kuemmel S; University Clinics Cologne, Women's Clinic and Breast Center, Cologne, Germany.
  • Zu Eulenburg C; West German Study Group, Moenchengladbach, Germany.
  • Braun M; Ev. Bethesda Hospital, Moenchengladbach, Germany.
  • Aktas B; West German Study Group, Moenchengladbach, Germany.
  • Grischke EM; Clinics Essen-Mitte, Breast Unit, Essen, Germany.
  • Schumacher C; Charité, Women's Clinic, Berlin, Germany.
  • Luedtke-Heckenkamp K; West German Study Group, Moenchengladbach, Germany.
  • Kates R; Clinics Rotkreuz, Breast Center, Munich, Germany.
  • Wuerstlein R; University Clinics Essen, Women's Clinic, Essen, Germany.
  • Graeser M; University Clinics Leipzig, Women's Clinic, Leipzig, Germany.
  • Harbeck N; University Clinics Tuebingen, Women's Clinic, Tuebingen, Germany.
  • Christgen M; St. Elisabeth Hospital, Cologne, Germany.
  • Kreipe H; Niels Stensen Clinics, Clinics for Oncology, Osnabrueck, Germany.
Cancer Med ; 10(23): 8581-8594, 2021 12.
Article en En | MEDLINE | ID: mdl-34779146
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias de la Mama / Proteína p53 Supresora de Tumor / Resistencia a Antineoplásicos Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Cancer Med Año: 2021 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias de la Mama / Proteína p53 Supresora de Tumor / Resistencia a Antineoplásicos Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Cancer Med Año: 2021 Tipo del documento: Article País de afiliación: Alemania